These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-IBD in Seniors. Shaffer SR; Kuenzig ME; Windsor JW; Bitton A; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Tandon P; St-Pierre J; Natt N; Davis T; Weinstein J; Im JHB; Benchimol EI; Kaplan GG; Goddard Q; Gorospe J; Bergevin M; Silver K; Bowles D; Stewart M; Pearlstein M; Dawson EH; Bernstein CN J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S45-S54. PubMed ID: 37674503 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease surgery in the biologic era. Ferrari L; Krane MK; Fichera A World J Gastrointest Surg; 2016 May; 8(5):363-70. PubMed ID: 27231514 [TBL] [Abstract][Full Text] [Related]
15. Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials. Shehab M; Alrashed F; Alkazemi A; Lakatos PL; Bessissow T Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):469-477. PubMed ID: 36961082 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Dual Biologic Therapy in Patients With Inflammatory Bowel Disease: A Review of the Literature. Gold SL; Steinlauf AF Gastroenterol Hepatol (N Y); 2021 Sep; 17(9):406-414. PubMed ID: 34602905 [No Abstract] [Full Text] [Related]
18. Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches. Privitera G; Pugliese D; Lopetuso LR; Scaldaferri F; Neri M; Guidi L; Gasbarrini A; Armuzzi A Therap Adv Gastroenterol; 2021; 14():17562848211006669. PubMed ID: 33995579 [TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia. AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388 [TBL] [Abstract][Full Text] [Related]